ponatinib
A multi-targeted tyrosine-kinase inhibitor, Ponatinib is used in treating chronic myeloid leukemia. Shows antiangiogenic and antineoplastic activities.Reference standards of Ponatinib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => 3-Bromoimidazo[1,2-b]pyridazine
[catalogue_number] => PA 16 91550
[category_ids] => ,84,
[chemical_name] =>
[weight] => 198.02
[form] => C6H4BrN3
[cas] => 18087-73-5
[pslug] => 18087-73-5-3-bromoimidazo-1-2-b-pyridazine-pa1691550
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
3-Bromoimidazo[1,2-b]pyridazine
Catalogue No.:PA 16 91550
Molecular Formula : C6H4BrN3
Molecular Weight : 198.02